Sunday - December 22, 2024

Crystalline Hydrochloride Salts of N-Ethyl-2-(5-Fluoro-1h-Indol-3-Yl)-N-Methylethan-1-Amine

ALEXANDRIA, Virginia, Dec. 3 -- GILGAMESH PHARMACEUTICALS, INC., New York, New York has been assigned a patent (No. US 12157722 B1, initially filed Sept. 14, 2023) developed by four inventors Andrew Carry Kruegel, Millington, New Jersey; William Leong, Westfield, New Jersey; Yameng He, Halifax, Canada; and Lauren MacEachern, Halifax, Canada, for "Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine." . . .

Information Request Form

Name:
Category that best fits the type
of business or agency you are
affiliated with:
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:
I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest.
If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method.
Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Copyright Targeted News Service 2024